Unité de Fabrication des Médicaments S.A

BVMT:UMED Stock Report

Market Cap: د.ت230.1m

Unité de Fabrication des Médicaments Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Ridha Charfeddine

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure3.8yrs
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

No updates

Recent updates


CEO

Ridha Charfeddine

3.8yrs

Tenure

Mr. Ridha Charfeddine is the Chief Executive Officer at Unité de Fabrication des Médicaments since June 12, 2020. He is the President of the Board of Directors at Société UNIMED.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.